Our Services
Apply Now! For Supplies
Patient Reorders
Patient Info Changes
Product Information
Alternate-Site Testing
About Diabetes
Insurance Coverage
Nutritional Information
New Technology
Diabetic Recipes
Diabetic Links
Contact Us
Search
Tell a Friend
Translate this Site
Home
Privacy Practices
Press Releases
Affiliate Program

DiasensorÆ, the world's first noninvasive blood glucose monitor, painlessly and simply measures blood glucose without the need to draw blood and without inconvenient, expensive extra supplies.

 

Our model demonstrates how the Diasensor operates by placing her forearm on the arm tray and painlessly testing her blood sugar in less than two minutes.

Visit the Diasensor site 

 


The Diasensor 1000 - A Breakthrough in Noninvasive Technology

The Diasensor 1000, the world’s first commercially available noninvasive blood glucose monitor, is approved for sale in the 15-nation European Union, where it is presently being marketed. It is not yet approved by the FDA for sale in the United States. Unlike currently marketed invasive home-use devices, the Diasensor 1000 does not require that patients prick their fingers to obtain a sample of blood to test their blood glucose. A patient only needs to place his or her arm on the Diasensor 1000 and press a button to perform a blood glucose test.

The Diasensor 2000 - A Direct Link to the Clinician

The Diasensor 2000, identical in appearance and operation to the Diasensor 1000, contains enhancements to the operating software and a telemedicine feature to improve diabetes management by clinicians.

Current Intended Use of the Diasensor

Due to current limitations in this brand new technology, the Diasensor is not for everyone. It is not intended as a replacement for the current invasive home-use blood glucose meter. It is intended to promote greater compliance for self-monitoring for those patients concerned with the pain and discomfort of frequent finger prick procedures by allowing patients to perform the majority of their daily blood glucose monitoring with a noninvasive device.

At this time, averages of blood glucose test results obtained at clinically relevant times of the day (e.g., fasting, pre-meal, post-meal and bedtime) over at least 15 to 30-day periods are intended to be used by physicians together with other laboratory tests, such as glycosylated hemoglobin (HbA1c) and fructosamine, patient-reported acute complications such as low blood glucose (hypoglycemia), changes in weight and changes in lifestyle, to adjust their patients’ diabetes therapy. Individual test results from the Diasensor are not intended to be used by patients to make daily adjustments to their insulin therapy, and the Diasensor should not be used to detect or monitor for hypoglycemia.



Home ] Up ]


Back ] Home ] Up ]
Copyright © 2004 American Diabetes Services, Inc. All rights reserved.